Cue Biopharma Long Term Deferred Charges (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3795 -0.01 (-1.94%) USD | NASDAQ | Jan 08, 16:00

0.4001 +0.02 (+5.43%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Puma Biotechnology, Inc.	--
Mersana Therapeutics, Inc.	--
Adaptive Biotechnologies Corp.	--
NovaBay Pharmaceuticals, Inc.	--